[Idiopathic hyperaldosteronism (IHA)].
Miyashita K, Itoh H, Nakao K.
Nihon Rinsho. 2006 May 28;Suppl 1:624-7.
The Value of Targeting CXCR4 With 68Ga-Pentixafor PET/CT for Subtyping Primary Aldosteronism.
Zheng Y, Long T, Peng N, Zhen M, Ye Q, Zhang Z, He Y, Chen Z, Gan Y, Luo M, Li C, Liu Z, Guo M, Wang M, Luo X, Hu S, Liu L, Jiang T.
J Clin Endocrinol Metab. 2023 Dec 21;109(1):171-182. doi: 10.1210/clinem/dgad421.
Hyperaldosteronism in pregnancy.
Escher G.
Ther Adv Cardiovasc Dis. 2009 Apr;3(2):123-32. doi: 10.1177/1753944708100180. Epub 2009 Jan 26.
Characterization of Aldosterone-producing Cell Cluster (APCC) at Single-cell Resolution.
Iwahashi N, Umakoshi H, Seki T, Gomez-Sanchez CE, Mukai K, Suematsu M, Umezawa Y, Oya M, Kosaka T, Seki M, Suzuki Y, Horiuchi Y, Ogawa Y, Nishimoto K.
J Clin Endocrinol Metab. 2022 Aug 18;107(9):2439-2448. doi: 10.1210/clinem/dgac394.
Cellular and Genetic Causes of Idiopathic Hyperaldosteronism.
Omata K, Satoh F, Morimoto R, Ito S, Yamazaki Y, Nakamura Y, Anand SK, Guo Z, Stowasser M, Sasano H, Tomlins SA, Rainey WE.
Hypertension. 2018 Oct;72(4):874-880. doi: 10.1161/HYPERTENSIONAHA.118.11086.
Safety and efficacy of bilateral superselective adrenal arterial embolization for treatment of idiopathic hyperaldosteronism: a prospective single-center study.
Mao M, Feng R, Khan NA, Tao L, Tang P, Zhao Y, Chen J, Li X, Zhao H, Shi Q, Wang L, Lyu F, Asghar MA, He Y, Chang J, Xiang R.
BMC Surg. 2024 Aug 24;24(1):242. doi: 10.1186/s12893-024-02530-z.
Effects of a low-sodium diet in patients with idiopathic hyperaldosteronism: a randomized controlled trial.
Zhou L, Jiang Y, Zhang C, Su T, Jiang L, Zhou W, Zhong X, Wu L, Wang W.
Front Endocrinol (Lausanne). 2023 Apr 19;14:1124479. doi: 10.3389/fendo.2023.1124479. eCollection 2023.
Obesity as a Key Factor Underlying Idiopathic Hyperaldosteronism.
Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, Kurihara I, Umakoshi H, Ichijo T, Katabami T, Wada N, Ogawa Y, Yoshimoto T, Kawashima J, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Miyauchi S, Kamemura K, Fukuoka T, Yamamoto K, Otsuki M, Suzuki T, Naruse M; JPAS Study Group.
J Clin Endocrinol Metab. 2018 Dec 1;103(12):4456-4464. doi: 10.1210/jc.2018-00866.
Associations between thyroid function, thyroid diseases, and primary aldosteronism.
Maiturouzi M, Zhu Q, Zhang D, Luo Q, Wang M, Cai X, Heizhati M, Cai L, Wu T, Liu S, Dang Y, Aimudula A, Hong J, Li N.
Eur J Endocrinol. 2024 Aug 5;191(2):262-270. doi: 10.1093/ejendo/lvae087.
Bilateral adrenal artery embolization for the treatment of idiopathic hyperaldosteronism: A proof-of-principle single center study.
Ji G, Yang C, Hou J, Zhou Y, Luo T, Yang Y, Wang D, Liu S, Wan J, He G, Zeng A, Wang X, Wang P.
Hypertens Res. 2025 Jan;48(1):200-211. doi: 10.1038/s41440-024-01897-z. Epub 2024 Sep 19.
